Dokumentuaren aipamena
APA (7th ed.) Zitazioa
Lee, H., Han, S. J., Ok, S., Lee, K. M., Choi, S., Yoon, I., . . . Yang, S. (2025). A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling. Frontiers Media S.A.
Ondo kopiatu da
Kopiatzeak huts egin du
Chicago Style (17th ed.) Zitazioa
Lee, Hyemi, et al. A Novel Carboxamide Bromodomain Inhibitor Attenuates Osteoarthritis via Epigenetic Repression of NF-κB and MAPK Signaling. Frontiers Media S.A, 2025.
Ondo kopiatu da
Kopiatzeak huts egin du
MLA (9th ed.) Zitazioa
Lee, Hyemi, et al. A Novel Carboxamide Bromodomain Inhibitor Attenuates Osteoarthritis via Epigenetic Repression of NF-κB and MAPK Signaling. Frontiers Media S.A, 2025.
Ondo kopiatu da
Kopiatzeak huts egin du
Kontuz: berrikusi erreferentzia hauek erabili aurretik.